- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Urinary Human Kidney Injury Molecule-1 (hKIM-1) Is Not Increased in Patients with Renal Cell Carcinoma.
October 2, 2020
Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation.
October 1, 2020
Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis.
October 1, 2020
The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.
October 1, 2020
Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
September 30, 2020
Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
September 30, 2020
Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
September 28, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.
September 28, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
September 25, 2020
Poststreptococcal acute glomerulonephritis in a girl with renal cell carcinoma: possible pathophysiological association.
September 25, 2020
Association of Surgical Delay and Overall Survival in Patients with T2 Renal Masses: Implications for Critical Clinical Decision-Making during the COVID-19 Pandemic.
September 25, 2020